High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma
Completed · Phase 2
Conditions studied: Multiple Myeloma
In brief
To assess the role of autologous hematopoietic cell rescue in the treatment of multiple myeloma.
Key facts
- Study ID
- NCT00186238
- Run by
- Stanford University
- People needed
- 300
- Starts
- 1994-09-01
- Expected to finish
- 2010-04-01
- Last updated by the study team
- 2010-09-14
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.